You are here: Industry Insights > Twist

News List

Twist Bioscience agrees to acquire Abveris for $190m Pharmaceutical-Technology
November 24, 2021
Twist Bioscience has signed a definitive agreement to acquire in vivo antibody discovery services firm Abveris for up to $190m to boost its biopharma expertise.
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics ExpressPharma
November 19, 2021
Twist Bioscience Corporation has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop and commercialize an antibody...
Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy prnasia
October 13, 2021
The Twist Alliance Pan-Cancer Methylation Panel (Pan-Cancer Panel), a solution for pan-cancer study including DNA methylation library preparation and targeted enrichment for next-generation sequencing (NGS)...